Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT01566175

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01566175
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Israel (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT01566175. Allocation not applicable; no masking; primary purpose treatment. Start 2011-08-30 (actual); primary completion 2030-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization
Acronym
Reducer
Condition
Refractory Angina
Intervention (Device)
Neovac coronary sinus reducer
Lead sponsor
Tel-Aviv Sourasky Medical Center (class: other government)
Collaborator
Shockwave Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01566175
Content hash
1f2accefee7bbae698afe0b2a167d1177fd3f1e8c5b0428fffb042ee238b777a